AxoGen Inc at Jefferies Healthcare Conference Transcript
You can kick this off. Good morning, everyone, and welcome to day one of the Jefferies 2023 Healthcare Conference. My name is Mike Sarcone. I'm an analyst on the medical supplies and devices team.
And we're happy to kick off the med devices track today with Axogen. They're a leader in peripheral nerve repair. And from the company, we've got Karen Zaderej, Chairwoman, CEO, and President; and Pete Mariani, CFO. Karen and Pete, thanks for joining us today.
Thank you, Mike.
Thanks.
Questions & Answers
Great. So I guess just to kick off, just talking about recent performance, Axogen has posted mid to high teens growth in the last three quarters. And that includes 18% growth in 1Q. You maintained your 11% to 15% top-line sales growth guidance for 2023.
I guess, can you
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |